Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6166103 | Urology | 2014 | 8 Pages |
Abstract
In men undergoing biopsy, ASA and other NSAID use were associated with increased probability of detecting PC, whereas ASA use was associated with the risk of detecting CSPC. Although NSAID use might have a protective biological effect against PC, men who develop elevated prostate-specific antigen levels while on NSAIDs may nonetheless be less likely to have an inflammatory etiology and more likely to harbor PC. It may be warranted for clinicians to consider the influence of NSAIDs when evaluating patients being considered for biopsy.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Bimal Bhindi, David Margel, Robert J. Hamilton, Kimberly A. Fernandes, Greg Trottier, Karen M. Hersey, Antonio Finelli, John Trachtenberg, Alexandre Zlotta, Girish S. Kulkarni, Ants Toi, Andrew Evans, Theodorus H. van der Kwast, Neil E. Fleshner,